Clinical and Experimental Reproductive Medicine

The impact of chronic insomnia disorder on menstruation and ovarian reserve in childbearing-age women: A cross-sectional study: Minmin Gong, Yang Gao, Zhi Wang, Fuer Lu, Hui Dong; Received September 6, 2023 Accepted November 30, 2023; DOI: https://doi.org/10.5653/cerm.2023.06513 [Epub ahead of print]; Full text PubReader ePub PDF

Measurement of serum anti-Müllerian hormone by revised Gen II or automated assay: Reproducibility under various blood/serum storage conditions: Joong Yeup Lee, Chung Hyon Kim, Seung-Ah Choe, Soyeon Seo, Seok Hyun Kim; Clin Exp Reprod Med. 2023;50(2):107-116. Published online May 24, 2023; DOI: https://doi.org/10.5653/cerm.2022.05687; Full text PubReader ePub PDF

Correlation of oocyte number with serum anti-Müllerian hormone levels measured by either Access or Elecsys in fresh in vitro fertilization cycles: Hye Gyeong Jeong, Seul Ki Kim, Jung Ryeol Lee, Byung Chul Jee; Clin Exp Reprod Med. 2022;49(3):202-209. Published online August 31, 2022; DOI: https://doi.org/10.5653/cerm.2022.05211
Web of Science 1 Crossref 1; Full text PubReader ePub PDF

Efficacy of ablation and sclerotherapy for the management of ovarian endometrioma: A narrative review: Byung Chul Jee; Clin Exp Reprod Med. 2022;49(2):76-86. Published online May 4, 2022; DOI: https://doi.org/10.5653/cerm.2021.05183
Web of Science 3 Crossref 3; Full text PubReader ePub PDF

Clinical application of serum anti-Müllerian hormone in women: So Ra Oh, Sun Yi Choe, Yeon Jean Cho; Clin Exp Reprod Med. 2019;46(2):50-59. Published online June 1, 2019; DOI: https://doi.org/10.5653/cerm.2019.46.2.50
Web of Science 37 Crossref 39; Full text PubReader ePub PDF

The likelihood of achieving pregnancy through timed coitus in young infertile women with decreased ovarian reserve: Hwa Seon Koo, In Ok Song, Sun Hwa Cha, Chan Woo Park, Hye Ok Kim; Clin Exp Reprod Med. 2018;45(1):31-37. Published online March 30, 2018; DOI: https://doi.org/10.5653/cerm.2018.45.1.31
Web of Science 10 Crossref 10; Full text PubReader PDF

Anti-Müllerian hormone as a predictor of polycystic ovary syndrome treated with clomiphene citrate: Andon Hestiantoro, Yuwono Sri Negoro, Yohana Afrita, Budi Wiweko, Kanadi Sumapradja, Muharam Natadisastra; Clin Exp Reprod Med. 2016;43(4):207-214. Published online December 26, 2016; DOI: https://doi.org/10.5653/cerm.2016.43.4.207
Crossref 2; Full text PubReader PDF

The meaning of anti-Müllerian hormone levels in patients at a high risk of poor ovarian response: Hyun Jong Park, Geun Ho Lee, Du Sik Gong, Tae Ki Yoon, Woo Sik Lee; Clin Exp Reprod Med. 2016;43(3):139-145. Published online September 22, 2016; DOI: https://doi.org/10.5653/cerm.2016.43.3.139
Crossref 9; Full text PubReader PDF

Application of serum anti-Müllerian hormone levels in selecting patients with polycystic ovary syndrome for in vitro maturation treatment: Hyun Ha Seok, Haengseok Song, Sang Woo Lyu, You Shin Kim, Dong Ryul Lee, Woo Sik Lee, Tae Ki Yoon; Clin Exp Reprod Med. 2016;43(2):126-132. Published online June 23, 2016; DOI: https://doi.org/10.5653/cerm.2016.43.2.126
Crossref 11; Full text PubReader PDF

Nomogram to predict the number of oocytes retrieved in controlled ovarian stimulation: Kyoung Yong Moon, Hoon Kim, Joong Yeup Lee, Jung Ryeol Lee, Byung Chul Jee, Chang Suk Suh, Ki Chul Kim, Won Don Lee, Jin Ho Lim, Seok Hyun Kim; Clin Exp Reprod Med. 2016;43(2):112-118. Published online June 23, 2016; DOI: https://doi.org/10.5653/cerm.2016.43.2.112
Crossref 23; Full text PubReader PDF

Anti-Müllerian hormone levels as a predictor of clinical pregnancy in in vitro fertilization/intracytoplasmic sperm injection-embryo transfer cycles in patients over 40 years of age: Hyun Jong Park, Sang Woo Lyu, Hyun Ha Seok, Tae Ki Yoon, Woo Sik Lee; Clin Exp Reprod Med. 2015;42(4):143-148. Published online December 31, 2015; DOI: https://doi.org/10.5653/cerm.2015.42.4.143
Crossref 10; Full text PubReader PDF

Serum luteinizing hormone level and luteinizing hormone/follicle-stimulating hormone ratio but not serum anti-Müllerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndrome: Sungwook Chun; Clin Exp Reprod Med. 2014;41(2):86-91. Published online June 30, 2014; DOI: https://doi.org/10.5653/cerm.2014.41.2.86
Crossref 25; Full text PubReader PDF

Can high serum anti-Müllerian hormone levels predict the phenotypes of polycystic ovary syndrome (PCOS) and metabolic disturbances in PCOS patients?: Yu Im Hwang, Na Young Sung, Hwa Seon Koo, Sun Hwa Cha, Chan Woo Park, Jin Yeong Kim, Kwang Moon Yang, In Ok Song, Mi Kyoung Koong, Inn Soo Kang, Hye Ok Kim; Clin Exp Reprod Med. 2013;40(3):135-140. Published online September 30, 2013; DOI: https://doi.org/10.5653/cerm.2013.40.3.135
Crossref 10; Full text PubReader PDF

Association between serum anti-Müllerian hormone level and ovarian response to mild stimulation in normoovulatory women and anovulatory women with polycystic ovary syndrome: Ju Yeong Kim, Gwang Yi, Yeo Rang Kim, Jae Yeon Chung, Ji Hyun Ahn, You Kyoung Uhm, Byung Chul Jee, Chang Suk Suh, Seok Hyun Kim; Clin Exp Reprod Med. 2013;40(2):95-99. Published online June 30, 2013; DOI: https://doi.org/10.5653/cerm.2013.40.2.95
Crossref 6; Full text PubReader PDF

Clinical application of anti-Müllerian hormone as a predictor of controlled ovarian hyperstimulation outcome: Jae Eun Lee, Jung Ryeol Lee, Byung Chul Jee, Chang Suk Suh, Ki Chul Kim, Won Don Lee, Seok Hyun Kim; Clin Exp Reprod Med. 2012;39(4):176-181. Published online December 31, 2012; DOI: https://doi.org/10.5653/cerm.2012.39.4.176
Crossref 10; Full text PubReader PDF

Search